Beranda › Neurofibroma Pleksiform › Maryland
Uji klinis Neurofibroma Pleksiform di Maryland
6 studi untuk Neurofibroma Pleksiform mencari peserta di lokasi di Maryland.
Teks studi resmi (Bahasa Inggris)
Development and Validation of Patient Reported Outcome (PRO) Measures for Individuals With Neurofibromatosis 1 (NF1) and Plexiform Neurofibromas (pNFs)
- National Institutes of Health Clinical Center, Bethesda
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 5 ke atas · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT02544022Surveillance for Malignant Transformation of Neurofibromatosis Type 1 (NF1) Related Peripheral Nerve Sheath Tumors (PNST)
- National Institutes of Health Clinical Center, Bethesda
Menerima pesertaStudi observasional
Usia 3 hingga 120 · Semua jenis kelamin · Diperbarui 2 Sep 2026 · NCT06222203Phase I Trial of TURALIO(R) (Pexidartinib, PLX3397) in Children and Young Adults With Refractory Leukemias and Refractory Solid Tumors Including Neurofibromatosis Type 1 (NF1) Associated Plexiform Neurofibromas (PN) and Tenosynovial Giant Cell Tumor ...
- National Institutes of Health Clinical Center, Bethesda
Menerima pesertaFase 1
Usia 3 hingga 35 · Semua jenis kelamin · Diperbarui 24 Agu 2026 · NCT02390752A Phase 2, Open-Label Study to Evaluate the Safety and Effects of HLX-1502 in Patients With Neurofibromatosis Type 1
- Johns Hopkins Hospital, Baltimore
Menerima pesertaFase 2
Usia 12 ke atas · Semua jenis kelamin · Diperbarui 29 Jul 2026 · NCT06541847A Study to Evaluate the Feasibility of a Physiologic Biomarker to Assess Pain and Other Sensory Problems Using Pupillometry in Participants With Neurofibromatosis Type 1 (NF1)
- National Institutes of Health Clinical Center, Bethesda
Menerima peserta
Usia 1 hingga 120 · Semua jenis kelamin · Diperbarui 9 Jun 2026 · NCT06507748Selumetinib for the Prevention of Plexiform Neurofibroma Growth in NF Type 1
- Johns Hopkins University, Baltimore
- National Cancer Institute/ National Institutes of Health, Bethesda
Menerima pesertaFase 2
Usia 1 hingga 8 · Semua jenis kelamin · Diperbarui 29 Mei 2026 · NCT06188741Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.